Does Rallies show 13F holders for MAIA?

Yes. Rallies tracks hedge fund and 13F ownership data for MAIA, including fund names, share counts, latest tracked quarter, and position changes when available.

Is MAIA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MAIA. It does not provide personalized investment advice.

MAIA (MAIA Biotechnology, Inc.) Stock Analysis - Hedge Fund Holdings

MAIA Biotechnology, Inc. (MAIA) is a publicly traded Healthcare sector company. As of May 21, 2026, MAIA trades at $1.29 with a market cap of $76.61M and a P/E ratio of -1.82. MAIA moved +3.66% today. Year to date, MAIA is -14.57%; over the trailing twelve months it is -29.12%. Its 52-week range spans $0.87 to $3.48. Analyst consensus is buy with an average price target of $14.00. Rallies surfaces MAIA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns MAIA stock?

Hedge funds tracked by Rallies that own MAIA include Citadel Advisors and Renaissance Technologies. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for MAIA Biotechnology, Inc..

MAIA Key Metrics

Key financial metrics for MAIA
Metric	Value
Price	$1.29
Market Cap	$76.61M
P/E Ratio	-1.82
EPS	$-0.70
Dividend Yield	0.00%
52-Week High	$3.48
52-Week Low	$0.87
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-22.40M
Gross Margin	0.00%

Top Hedge Funds Holding MAIA

Citadel Advisors holds 23.75K shares of MAIA, changed -58.68% as of Mar 31, 2024.
Renaissance Technologies holds 19.00K shares of MAIA, changed -82.91% as of Mar 31, 2024.

Latest MAIA News

MAIA Biotechnology Raises $30 Million Through 20M-Share Public Offering — Mar 4, 2026
MAIA Biotechnology Advances Phase 3 Trial of Ateganosine for 3L NSCLC in $50B Market — Feb 24, 2026

Recent MAIA Insider Trades

Smith Stan bought 57.19K (~$70.00K) on Dec 22, 2025.
CHAOUKI STEVEN M bought 40.85K (~$50.00K) on Dec 22, 2025.
Louie Ngar Yee bought 81.70K (~$100.00K) on Dec 22, 2025.

MAIA Analyst Consensus

1 analysts cover MAIA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.00.

Common questions about MAIA

Who owns MAIA stock?: Hedge funds tracked by Rallies that own MAIA include Citadel Advisors and Renaissance Technologies. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for MAIA Biotechnology, Inc..
Does Rallies show 13F holders for MAIA?: Yes. Rallies tracks hedge fund and 13F ownership data for MAIA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is MAIA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MAIA. It does not provide personalized investment advice.